APA (7th ed.) Citation

Kessler, C., Wilke, C., Hengel, H., Rattay, T. W., Maleska Maceski, A., Kuhle, J., . . . Schüle-Freyer, R. (2025). Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4. Amyotrophic lateral sclerosis & frontotemporal degeneration. https://doi.org/10.1080/21678421.2025.2557936

Chicago Style (17th ed.) Citation

Kessler, Christoph, Carlo Wilke, Holger Hengel, Tim W. Rattay, Aleksandra Maleska Maceski, Jens Kuhle, Ludger Schöls, and Rebecca Schüle-Freyer. "Serum NfL, but Not GFAP, Differentiates Primary Lateral Sclerosis from Adrenomyeloneuropathy and Hereditary Spastic Paraplegia Type 4." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 2025. https://doi.org/10.1080/21678421.2025.2557936.

MLA (9th ed.) Citation

Kessler, Christoph, et al. "Serum NfL, but Not GFAP, Differentiates Primary Lateral Sclerosis from Adrenomyeloneuropathy and Hereditary Spastic Paraplegia Type 4." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2025, https://doi.org/10.1080/21678421.2025.2557936.